July 17, 2024

Non-Oncology Precision Medicine Market Size to Hit Around US$ 150.2 bn by 2030

Precedence Research a new report on non-oncology precision medicine market size, share, growth, industry trends, and forecast 2030, covering various industry elements and growth trends helpful for predicting the market’s future. The global non-oncology precision medicine market size was valued at US$ 63.79 billion in 2021. The global non-oncology precision medicine market is projected to reach US$ 150.2 billion by 2030, registering a compound annual growth rate (CAGR) of 9.98% during the forecast period from 2022 to 2030.

Non-Oncology Precision Medicine

Download Free Sample Copy with TOC@ https://www.precedenceresearch.com/sample/1798

The global non-oncology precision medicine market report offers various segments analysis by size, trends, growth factors, opportunities and key country outlook to 2030. The report offers a detailed analysis and information as per non-oncology precision medicine, market segments helping our readers to get a comprehensive overview of the global market. Several players are planning to focus on developing cost-effective products or services, aiming to maintain a strong foothold in the market.

Non-Oncology Precision Medicine Market Report Scope 
Report Coverage Details
Market Size by 2030 USD 150.2 Billion
Growth Rate from 2022 to 2030 CAGR of 9.98%
Largest Market North America
Fastest Growing Region Asia Pacific
Base Year 2021
Forecast Period 2022 to 2030
Segments Covered Product, Application, End-use, Ecosystem, Geography

The company profiling of leading market players is included this report with Porter’s five forces analysis and Value Chain analysis. Further, the strategies exercised by the companies for expansion of business through mergers, acquisitions, and other business development measures are discussed in the report. The financial parameters which are assessed include the sales, profits and the overall revenue generated by the key players of Market.

Read Also@ Electric Vehicle Tire Market to Witness Massive Growth from 2022 to 2030

Some of the prominent players in the non-oncology precision medicine market include:
  • Pfizer Inc.
  • Qiagen Inc.
  • Quest Diagnostics Inc.
  • Medtronic
  • Novartis
  • Laboratory Corporation of America Holdings
  • bioMérieux SA
  • Abbott Laboratories
  • F. Hoffmann-La Roche A
  • Eli Lilly & Company
Non-Oncology Precision Medicine Market Segmentation

By Product Type

  • Diagnostics
    • Genetic Tests
    • Biomarker Based Tests
    • Others
  • Therapeutics

By Application

  • Oncology
  • CNS
  • Immunology
  • Respiratory
  • Infectious Diseases
    • Respiratory Infections
    • Gastrointestinal Infections
    • Sexually Transmitted Infections
    • Others
  • Neurology
    • Neurodegenerative Disorders
    • Neuropsychiatric Disorders
    • Others
  • Cardiovascular
    • Cardiac Myopathies and Arrhythmia
    • Others
  • Lifestyle and Endocrinology
  • Gastroenterology
  • Others

By End-use

  • Hospitals
  • Diagnostic Centers
  • Research & Academic Institutes
  • Others

By Ecosystem

  • Applied Sciences
    • Genomics
    • By Technology
      • Polymerase Chain Reaction (PCR)
      • Precision Medicine Next-Generation Sequencing (PM NGS)
      • Genome Editing
      • Other Technologies
    • Pharmacogenomics
    • Other Applied Sciences
  • Precision Diagnostics
    • Molecular Diagnostics (MDx)
    • Medical Imaging
  • Digital Health and Information Technology
    • Clinical Decision Support Systems (CDSS)
    • Big Data Analytics
    • IT Infrastructure
    • Genomics Informatics
    • In-Silico Informatics
    • Mobile Health
  • Precision Therapeutics
    • Clinical Trials
    • Cell Therapy
    • Drug Discovery and Research
    • Gene Therapy

Regional Segmentation

  • Asia-Pacific [China, Southeast Asia, India, Japan, Korea, Western Asia]
  • Europe [Germany, UK, France, Italy, Russia, Spain, Netherlands, Turkey, Switzerland]
  • North America [United States, Canada, Mexico]
  • South America [Brazil, Argentina, Columbia, Chile, Peru]
  • Middle East & Africa [GCC, North Africa, South Africa]

Key Questions are

  • What are the key factors influencing the non-oncology precision medicine market in each region?
  • How much value will the global market generate by the end of the forecast period?
  • What will be the CAGR of the global market between 2022 and 2030?
  • What would be the Y-o-Y growth trend of the global market between 2022 and 2030?
  • What is the future scope and current trends in technologies of the global market?
  • What is the revenue of the global market based on segments?
  • Which key strategies are used by top players of the global market?
  • Which are the leading companies in the global market?
  • What are the essential strategies by key stakeholders in the market to expand their geographic presence?
  • What are the major advancements witnessed in the global market?

Research Objectives and Research Approach

The comprehensive report on the global non-oncology precision medicine market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products. Following this, the report provides detailed explanation of objectives of this study and laid down by accredited agencies in the purview of research in the global non-oncology precision medicine market.

It is followed by market introduction, market dynamics, and an overview of the global market, which includes analysis of market drivers, restraints, and trends pertaining to the global market. Furthermore, Y-o-Y growth analysis with elaborated insights has been provided in order to understand the Y-o-Y growth trend of the global market.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller sections. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global non-oncology precision medicine market in terms of type, application, region and others. Key segments under each criteria are studied at length, and the market share for each of these at the end of 2030 has also been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global market.

Why should you invest in this report?

If you are aiming to enter the global non-oncology precision medicine market, this report is a comprehensive guide that provides crystal clear insights into this niche market. All the major application areas for non-oncology precision medicine are covered in this report and information is given on the important regions of the world where this market is likely to boom during the forecast period of 2022-2030 so that you can plan your strategies to enter this market accordingly.

Besides, through this report, you can have a complete grasp of the level of competition you will be facing in this hugely competitive market and if you are an established player in this market already, this report will help you gauge the strategies that your competitors have adopted to stay as market leaders in this market. For new entrants to this market, the voluminous data provided in this report is invaluable.

Table of Contents

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Non-Oncology Precision Medicine Market 

5.1. COVID-19 Landscape: Non-Oncology Precision Medicine Industry Impact

5.2. COVID 19 – Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Non-Oncology Precision Medicine Market, By Product Type

8.1. Non-Oncology Precision Medicine Market, by Product Type, 2022-2030

8.1.1. Diagnostics

8.1.1.1. Market Revenue and Forecast (2017-2030)

8.1.2. Therapeutics

8.1.2.1. Market Revenue and Forecast (2017-2030)

Chapter 9. Global Non-Oncology Precision Medicine Market, By Application

9.1. Non-Oncology Precision Medicine Market, by Application e, 2022-2030

9.1.1. Oncology

9.1.1.1. Market Revenue and Forecast (2017-2030)

9.1.2. CNS

9.1.2.1. Market Revenue and Forecast (2017-2030)

9.1.3. Immunology

9.1.3.1. Market Revenue and Forecast (2017-2030)

9.1.4. Respiratory

9.1.4.1. Market Revenue and Forecast (2017-2030)

9.1.5. Infectious Diseases

9.1.5.1. Market Revenue and Forecast (2017-2030)

9.1.6. Neurology

9.1.6.1. Market Revenue and Forecast (2017-2030)

9.1.7. Cardiovascular

9.1.7.1. Market Revenue and Forecast (2017-2030)

9.1.8. Lifestyle and Endocrinology

9.1.8.1. Market Revenue and Forecast (2017-2030)

9.1.9. Gastroenterology

9.1.9.1. Market Revenue and Forecast (2017-2030)

9.1.10. Others

9.1.10.1. Market Revenue and Forecast (2017-2030)

Chapter 10. Global Non-Oncology Precision Medicine Market, By End-use 

10.1. Non-Oncology Precision Medicine Market, by End-use, 2022-2030

10.1.1. Hospitals

10.1.1.1. Market Revenue and Forecast (2017-2030)

10.1.2. Diagnostic Centers

10.1.2.1. Market Revenue and Forecast (2017-2030)

10.1.3. Research & Academic Institutes

10.1.3.1. Market Revenue and Forecast (2017-2030)

10.1.4. Others

10.1.4.1. Market Revenue and Forecast (2017-2030)

Chapter 11. Global Non-Oncology Precision Medicine Market, By Ecosystem 

11.1. Non-Oncology Precision Medicine Market, by Ecosystem, 2022-2030

11.1.1. Applied Sciences

11.1.1.1. Market Revenue and Forecast (2017-2030)

11.1.2. Precision Diagnostics

11.1.2.1. Market Revenue and Forecast (2017-2030)

11.1.3. Digital Health and Information Technology

11.1.3.1. Market Revenue and Forecast (2017-2030)

11.1.4. Precision Therapeutics

11.1.4.1. Market Revenue and Forecast (2017-2030)

Chapter 12. Global Non-Oncology Precision Medicine Market, Regional Estimates and Trend Forecast

12.1. North America

12.1.1. Market Revenue and Forecast, by Product Type (2017-2030)

12.1.2. Market Revenue and Forecast, by Application (2017-2030)

12.1.3. Market Revenue and Forecast, by End-use (2017-2030)

12.1.4. Market Revenue and Forecast, by Ecosystem (2017-2030)

12.1.5. U.S.

12.1.5.1. Market Revenue and Forecast, by Product Type (2017-2030)

12.1.5.2. Market Revenue and Forecast, by Application (2017-2030)

12.1.5.3. Market Revenue and Forecast, by End-use (2017-2030)

12.1.5.4. Market Revenue and Forecast, by Ecosystem (2017-2030)

12.1.6. Rest of North America

12.1.6.1. Market Revenue and Forecast, by Product Type (2017-2030)

12.1.6.2. Market Revenue and Forecast, by Application (2017-2030)

12.1.6.3. Market Revenue and Forecast, by End-use (2017-2030)

12.1.6.4. Market Revenue and Forecast, by Ecosystem (2017-2030)

12.2. Europe

12.2.1. Market Revenue and Forecast, by Product Type (2017-2030)

12.2.2. Market Revenue and Forecast, by Application (2017-2030)

12.2.3. Market Revenue and Forecast, by End-use (2017-2030)

12.2.4. Market Revenue and Forecast, by Ecosystem (2017-2030)

12.2.5. UK

12.2.5.1. Market Revenue and Forecast, by Product Type (2017-2030)

12.2.5.2. Market Revenue and Forecast, by Application (2017-2030)

12.2.5.3. Market Revenue and Forecast, by End-use (2017-2030)

12.2.5.4. Market Revenue and Forecast, by Ecosystem (2017-2030)

12.2.6. Germany

12.2.6.1. Market Revenue and Forecast, by Product Type (2017-2030)

12.2.6.2. Market Revenue and Forecast, by Application (2017-2030)

12.2.6.3. Market Revenue and Forecast, by End-use (2017-2030)

12.2.6.4. Market Revenue and Forecast, by Ecosystem (2017-2030)

12.2.7. France

12.2.7.1. Market Revenue and Forecast, by Product Type (2017-2030)

12.2.7.2. Market Revenue and Forecast, by Application (2017-2030)

12.2.7.3. Market Revenue and Forecast, by End-use (2017-2030)

12.2.7.4. Market Revenue and Forecast, by Ecosystem (2017-2030)

12.2.8. Rest of Europe

12.2.8.1. Market Revenue and Forecast, by Product Type (2017-2030)

12.2.8.2. Market Revenue and Forecast, by Application (2017-2030)

12.2.8.3. Market Revenue and Forecast, by End-use (2017-2030)

12.2.8.4. Market Revenue and Forecast, by Ecosystem (2017-2030)

12.3. APAC

12.3.1. Market Revenue and Forecast, by Product Type (2017-2030)

12.3.2. Market Revenue and Forecast, by Application (2017-2030)

12.3.3. Market Revenue and Forecast, by End-use (2017-2030)

12.3.4. Market Revenue and Forecast, by Ecosystem (2017-2030)

12.3.5. India

12.3.5.1. Market Revenue and Forecast, by Product Type (2017-2030)

12.3.5.2. Market Revenue and Forecast, by Application (2017-2030)

12.3.5.3. Market Revenue and Forecast, by End-use (2017-2030)

12.3.5.4. Market Revenue and Forecast, by Ecosystem (2017-2030)

12.3.6. China

12.3.6.1. Market Revenue and Forecast, by Product Type (2017-2030)

12.3.6.2. Market Revenue and Forecast, by Application (2017-2030)

12.3.6.3. Market Revenue and Forecast, by End-use (2017-2030)

12.3.6.4. Market Revenue and Forecast, by Ecosystem (2017-2030)

12.3.7. Japan

12.3.7.1. Market Revenue and Forecast, by Product Type (2017-2030)

12.3.7.2. Market Revenue and Forecast, by Application (2017-2030)

12.3.7.3. Market Revenue and Forecast, by End-use (2017-2030)

12.3.7.4. Market Revenue and Forecast, by Ecosystem (2017-2030)

12.3.8. Rest of APAC

12.3.8.1. Market Revenue and Forecast, by Product Type (2017-2030)

12.3.8.2. Market Revenue and Forecast, by Application (2017-2030)

12.3.8.3. Market Revenue and Forecast, by End-use (2017-2030)

12.3.8.4. Market Revenue and Forecast, by Ecosystem (2017-2030)

12.4. MEA

12.4.1. Market Revenue and Forecast, by Product Type (2017-2030)

12.4.2. Market Revenue and Forecast, by Application (2017-2030)

12.4.3. Market Revenue and Forecast, by End-use (2017-2030)

12.4.4. Market Revenue and Forecast, by Ecosystem (2017-2030)

12.4.5. GCC

12.4.5.1. Market Revenue and Forecast, by Product Type (2017-2030)

12.4.5.2. Market Revenue and Forecast, by Application (2017-2030)

12.4.5.3. Market Revenue and Forecast, by End-use (2017-2030)

12.4.5.4. Market Revenue and Forecast, by Ecosystem (2017-2030)

12.4.6. North Africa

12.4.6.1. Market Revenue and Forecast, by Product Type (2017-2030)

12.4.6.2. Market Revenue and Forecast, by Application (2017-2030)

12.4.6.3. Market Revenue and Forecast, by End-use (2017-2030)

12.4.6.4. Market Revenue and Forecast, by Ecosystem (2017-2030)

12.4.7. South Africa

12.4.7.1. Market Revenue and Forecast, by Product Type (2017-2030)

12.4.7.2. Market Revenue and Forecast, by Application (2017-2030)

12.4.7.3. Market Revenue and Forecast, by End-use (2017-2030)

12.4.7.4. Market Revenue and Forecast, by Ecosystem (2017-2030)

12.4.8. Rest of MEA

12.4.8.1. Market Revenue and Forecast, by Product Type (2017-2030)

12.4.8.2. Market Revenue and Forecast, by Application (2017-2030)

12.4.8.3. Market Revenue and Forecast, by End-use (2017-2030)

12.4.8.4. Market Revenue and Forecast, by Ecosystem (2017-2030)

12.5. Latin America

12.5.1. Market Revenue and Forecast, by Product Type (2017-2030)

12.5.2. Market Revenue and Forecast, by Application (2017-2030)

12.5.3. Market Revenue and Forecast, by End-use (2017-2030)

12.5.4. Market Revenue and Forecast, by Ecosystem (2017-2030)

12.5.5. Brazil

12.5.5.1. Market Revenue and Forecast, by Product Type (2017-2030)

12.5.5.2. Market Revenue and Forecast, by Application (2017-2030)

12.5.5.3. Market Revenue and Forecast, by End-use (2017-2030)

12.5.5.4. Market Revenue and Forecast, by Ecosystem (2017-2030)

12.5.6. Rest of LATAM

12.5.6.1. Market Revenue and Forecast, by Product Type (2017-2030)

12.5.6.2. Market Revenue and Forecast, by Application (2017-2030)

12.5.6.3. Market Revenue and Forecast, by End-use (2017-2030)

12.5.6.4. Market Revenue and Forecast, by Ecosystem (2017-2030)

Chapter 13. Company Profiles

13.1. Pfizer Inc.

13.1.1. Company Overview

13.1.2. Product Offerings

13.1.3. Financial Performance

13.1.4. Recent Initiatives

13.2. Qiagen Inc.

13.2.1. Company Overview

13.2.2. Product Offerings

13.2.3. Financial Performance

13.2.4. Recent Initiatives

13.3. Quest Diagnostics Inc.

13.3.1. Company Overview

13.3.2. Product Offerings

13.3.3. Financial Performance

13.3.4. Recent Initiatives

13.4. Medtronic

13.4.1. Company Overview

13.4.2. Product Offerings

13.4.3. Financial Performance

13.4.4. Recent Initiatives

13.5. Novartis

13.5.1. Company Overview

13.5.2. Product Offerings

13.5.3. Financial Performance

13.5.4. Recent Initiatives

13.6. Laboratory Corporation of America Holdings

13.6.1. Company Overview

13.6.2. Product Offerings

13.6.3. Financial Performance

13.6.4. Recent Initiatives

13.7. bioMérieux SA

13.7.1. Company Overview

13.7.2. Product Offerings

13.7.3. Financial Performance

13.7.4. Recent Initiatives

13.8. Abbott Laboratories

13.8.1. Company Overview

13.8.2. Product Offerings

13.8.3. Financial Performance

13.8.4. Recent Initiatives

13.9. F. Hoffmann-La Roche A

13.9.1. Company Overview

13.9.2. Product Offerings

13.9.3. Financial Performance

13.9.4. Recent Initiatives

13.10. Eli Lilly & Company

13.10.1. Company Overview

13.10.2. Product Offerings

13.10.3. Financial Performance

13.10.4. Recent Initiatives

Chapter 14. Research Methodology

14.1. Primary Research

14.2. Secondary Research

14.3. Assumptions

Chapter 15. Appendix

15.1. About Us

15.2. Glossary of Terms

Buy This Premium Research Report Click Here@ https://www.precedenceresearch.com/checkout/1798

Our Press Release@ https://www.precedenceresearch.com/press-releases

About Us

Precedence Research is a Canada/India based company and one of the leading providers of strategic market insights. We offer executive-level blueprints of markets and solutions beyond flagship surveys. Our repository covers consultation, syndicated market studies, and customized research reports. Through our services we aim at connecting an organization’s goal with lucrative prospects globally.

From gauging investment feasibility to uncovering hidden growth opportunities, our market studies cover in-depth analysis, which also is interspersed with relevant statistics. Recommendation are often enclosed within our reports with the sole intent of enabling organizations achieve mission-critical success.

Contact Us:                  

Precedence Research

Apt 1408 1785 Riverside Drive Ottawa, ON, K1G 3T7, Canada

Call: +1 9197 992 333

Email: sales@precedenceresearch.com

Website: https://www.precedenceresearch.com

Leave a Reply

Your email address will not be published. Required fields are marked *